Fondo
|
Categoría VDOS
|
Valor liquidativo
|
Fecha
|
%
2022
|
%
3 años
|
Rating VDOS
|
|---|---|---|---|---|---|---|
| 'ABANTE GLOBAL FUNDS - ABANTE BIOTECH FUND A EUR HEDGED CAP | BIOTECNOLOGÍA | 5,971000 | 22/09 | -20,57% | -32,19% |
|
| 'NOMURA FUNDS IRELAND - GLOBAL DYNAMIC BOND FUND AD GBP HEDGED | RFI GLOBAL | 93,888443 | 22/09 | -21,34% | · |
|
| 'SCHRODER ISF EMERGING MARKETS VALUE E ACC USD | RVI EMERGENTES | 89,318798 | 22/09 | -2,62% | · |
|
| 1 KESSLER GLOBAL, FI | MIXTO FLEXIBLE | 6,747384 | 21/09 | 30,61% | -22,24% |
|
| A&G RENTA FIJA CORTO PLAZO, FI | MONETARIO EURO PLUS | 5,418759 | 22/09 | -2,09% | -2,29% |
|
| A&P LIFESCIENCE FUND, FI A | BIOTECNOLOGÍA | 6,821557 | 22/09 | -22,15% | · |
|
| A&P LIFESCIENCE FUND, FI B | BIOTECNOLOGÍA | 6,776137 | 22/09 | -22,63% | · |
|
| A&P LIFESCIENCE FUND, FI C | BIOTECNOLOGÍA | 0,000010 | 10/03 | · | · |
|
| AAF ARISTOTLE US EQUITIES A EUR CAP | RVI USA | 311,644000 | 15/09 | -6,56% | 37,34% |
|
| AAF ARISTOTLE US EQUITIES A USD CAP | RVI USA | 221,531225 | 15/09 | -6,90% | 37,35% |
|
| AAF ARISTOTLE US EQUITIES AH EUR CAP | RVI USA | 158,806000 | 15/09 | -19,56% | 16,60% |
|
| AAF ARISTOTLE US EQUITIES R EUR CAP | RVI USA | 167,086000 | 15/09 | -6,06% | 40,43% |
|
| AAF ARISTOTLE US EQUITIES R USD CAP | RVI USA | 141,260008 | 15/09 | -6,41% | 40,46% |
|
| AAF ARISTOTLE US EQUITIES R2 EUR CAP | RVI USA | 162,352000 | 15/09 | -6,13% | 40,01% |
|
| AAF ARISTOTLE US EQUITIES R2 USD CAP | RVI USA | 141,508207 | 15/09 | -6,45% | 40,05% |
|
| AAF ARISTOTLE US EQUITIES RH EUR CAP | RVI USA | 125,632000 | 15/09 | -19,13% | 19,24% |
|
| AAF BOSTON COMMON US SUSTAINABLE EQUITIES A EUR CAP | ÉTICO | 145,757000 | 15/09 | -1,66% | · |
|
| AAF BOSTON COMMON US SUSTAINABLE EQUITIES A USD CAP | ÉTICO | 115,347278 | 15/09 | -2,01% | · |
|
| AAF DANA US SUSTAINABLE EQUITIES A USD CAP | ÉTICO | 100,094348 | 08/10 | · | · |
|
| AAF EDENTREE EUROPEAN SUSTAINABLE EQUITIES A EUR CAP | ÉTICO | 119,025000 | 15/09 | -11,46% | 12,39% |
|
Información y tecnología suministrados por VDOS. Términos de uso.